Pharmsville Co., Ltd.
KOSDAQ
₩3,640.00
+0.00%
Delayed · cached 15 min
Fair value analysis
318010
Pharmsville Co., Ltd.
₩3,640.00
Close used for this calculation
₩5,300.22Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
71/100
Quality radar
Consensus fair value
₩5,300.22
Below FV▲ +45.6% against the close used
Model range ₩1,671.43 – ₩8,539.91
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩1,671.43Fair value₩5,300.22Bull₩8,539.91
FairClose
52-week traded range
52W low ₩3,195.0052W high ₩4,030.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
Pharmsville Co., Ltd. closed at ₩3,640.00, 31.3% below the consensus fair value of ₩5,300.22 drawn from 9 valuation models.
Financial DNA score 71/100 — Strong. P/E of 9.7x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩4,566.74
+25.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩8,539.91
+134.6%
√(22.5 × EPS × BVPS)
EPS=374, BVPS=8666.67
Graham Formula
₩4,238.67
+16.4%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=0%, FD=3.3%
P/E Fair Value
₩7,480.00
+105.5%
EPS × 20x (sector P/E)
EPS=374, Sector P/E=20x
Peter Lynch (PEG)
₩5,280.88
+45.1%
EPS × Growth% (PEG = 1 is fair)
EPS=374, g=14.1%
Dividend Discount (DDM)
₩2,701.06
-25.8%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=211.85, r=10%, g=2%
Book Value (P/B)
₩1,671.43
-54.1%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=8666.67, ROE=4.4%, g=3%, r=10%
Reverse DCF
₩3,640.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -2.7% | Historical: -14.1%
Margin of Safety
₩4,654.75
+27.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=6206.33, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.